In Conversation With... Richard Horton on the Oxford vaccine phase 3 trial

Editor-in-chief ofThe Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.

Source: Listen to The Lancet - December 9, 2020 Category: General Medicine Authors: The Lancet Source Type: podcasts